Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening
- PMID: 26646142
- DOI: 10.1097/AOG.0000000000001132
Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening
Erratum in
- Obstet Gynecol. 2016 Apr;127(4):806
Abstract
Objective: To evaluate whether one-step gestational diabetes screening recommended by The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) is associated with better maternal, perinatal, or neonatal outcomes than the two-step Carpenter-Coustan screening.
Methods: In this before-after retrospective cohort study conducted between July 1, 2010, and December 31, 2013, we compared Carpenter-Coustan and IADPSG screening in patients with singleton pregnancies. All patients diagnosed with gestational diabetes received intensive teaching, home glucose monitoring, and medications as indicated. The primary outcome was the rate of large-for-gestational-age neonates. Secondary outcome measures were macrosomia (greater than 4,000 g), primary cesarean delivery, neonatal intensive care unit admission, preterm delivery, preeclampsia, and hyperbilirubinemia. We determined that a sample size of 2,782 per group was sufficient to detect a 2% difference in the primary outcome between groups with 80% power assuming a 10% incidence in the before group. The groups were compared using Fisher exact test for proportions and a χ test for odds ratios.
Results: In the before (Carpenter-Coustan) group, 513 (17%) of the 2,972 patients were diagnosed with gestational diabetes, and in the after (IADPSG) group, 847 (27%) of the 3,094 patients were so diagnosed (P<.001). There was no significant difference in rates of large for gestational age, 10% and 9%, respectively (P=.25). The IADPSG group had a significantly higher primary cesarean delivery rate-16% compared with 20% (P<.001), but there were no significant differences in any other pregnancy outcomes.
Conclusion: Although one-step screening was associated with more patients being treated for gestational diabetes, it was not associated with a decrease in large-for-gestational-age or macrosomic neonates but was associated with an increased rate of primary cesarean delivery. Our results did not support the IADPSG-recommended screening protocol.
Comment in
-
Changing the Diagnostic Criteria for Gestational Diabetes Mellitus?Obstet Gynecol. 2016 Jan;127(1):3-6. doi: 10.1097/AOG.0000000000001225. Obstet Gynecol. 2016. PMID: 26646138 No abstract available.
-
Changing the Diagnostic Criteria for Gestational Diabetes Mellitus?: Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening.Obstet Gynecol. 2016 Apr;127(4):800. doi: 10.1097/AOG.0000000000001363. Obstet Gynecol. 2016. PMID: 27008221 No abstract available.
-
In Reply.Obstet Gynecol. 2016 Apr;127(4):801. doi: 10.1097/AOG.0000000000001377. Obstet Gynecol. 2016. PMID: 27008222 No abstract available.
-
Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening And: Changing the Diagnostic Criteria for Gestational Diabetes Mellitus?Obstet Gynecol. 2016 May;127(5):963. doi: 10.1097/AOG.0000000000001410. Obstet Gynecol. 2016. PMID: 27101108 No abstract available.
-
In Reply.Obstet Gynecol. 2016 May;127(5):963-964. doi: 10.1097/AOG.0000000000001411. Obstet Gynecol. 2016. PMID: 27101109 No abstract available.
-
Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening.Obstet Gynecol. 2016 May;127(5):964-965. doi: 10.1097/AOG.0000000000001413. Obstet Gynecol. 2016. PMID: 27101111 No abstract available.
-
In Reply.Obstet Gynecol. 2016 May;127(5):965. doi: 10.1097/AOG.0000000000001414. Obstet Gynecol. 2016. PMID: 27101112 No abstract available.
References
-
- Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 1980;3:458–64.
-
- Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Damm P. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 2008;87:59–62.
-
- Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, Farine D, et al.. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995;173:146–56.
-
- Ferrara A, Weiss NS, Hedderson MM, Quesenberry CP Jr, Selby JV, Ergas IJ, et al.. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 2007;50:298–306.
-
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Clinical practice guideline. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
